Bold shift in biotics: probiotics are driving a new consumer health boom, even in a stagnant market. But here’s where it gets controversial: the real story isn’t just higher sales, it’s how people are changing what they want from supplements.
Probiotic supplements are growing at a five-year compound annual rate of 4.5%, outpacing the overall consumer health and dietary supplement category, according to Euromonitor’s Stene, who leads the firm’s consumer health research program. This occurs even as global GDP growth and inflation hover around 3% last year, effectively balancing each other out.
Products offering multiple benefits are performing especially well—gut health, immunity, and beauty—what Stene calls the “triple stack.” He notes a broader shift in spending priorities: the experience economy remains robust as people invest to look and feel their best.
Biotic health claims and ingredient movements
By analyzing 1.6 million SKUs via web scraping, Stene mapped how biotics sit within the dietary supplement market. In North America, roughly 10% of dietary supplements carry the label probiotic, about 9% in Australasia, and around 5% in Europe, where regulatory hurdles may play a role and where the term probiotic can be treated as an unauthorized health claim. Still, probiotics are increasingly positioned as the “hero ingredient” in many supplements and are also rising as a supportive mechanism.
Prebiotics and postbiotics tend to play support roles and appear far less frequently. The term “prebiotic” shows up on fewer than 2% of dietary supplements worldwide, while “postbiotic” appears on fewer than 0.2%. Despite these low bases, both categories are growing across global markets.
Stene emphasizes a pattern of steady to rapid growth, but from a low starting point, describing it as more of a supporting message on SKUs than a primary selling point. Digestive and immune benefits are the most common claims on probiotic products, with a handful also promoting bone, joint, and liver health. Memory and cognition claims are rising, particularly for probiotics in Western Europe, but the standout growth driver appears to be beauty and skin health, especially where probiotic messaging overlaps with prebiotic and postbiotic strategies.
A notable case is Bloom, a global supplement brand that has embraced a triple-stack approach focusing on gut health, immunity, and beauty. Bloom’s strategy includes species- and strain-specific messaging to bolster credibility with consumers who increasingly value transparent, scientifically grounded claims.
Credibility matters. About 1 in 5 new SKUs now feature third-party certification, roughly double the level seen before the COVID period, indicating that independent verification is becoming a standard consumer expectation.
AI as a frontier for health advice and regulation
Looking ahead, Stene points to AI as both a growth engine and a regulatory enforcer. AI is already used to deliver personalized health guidance, including to older adults, and regulators are adopting the same technology to monitor compliance. Regulators are leveraging AI for market analysis to assess health claims, which means brands will have less leeway and more scrutiny in a shorter time frame.
In simple terms: expect more sophisticated, faster checks on what brands can claim—and more pressure to prove those claims with credible data. Brands should prepare now by investing in quality messaging, transparent ingredient details, and third-party verification to stay ahead of evolving oversight.
Discussion prompts: Do you prioritize gut health claims over beauty or cognitive benefits when choosing a probiotic? Should regulators push harder on “hero ingredient” branding, or protect consumers from overstated benefits? Share your thoughts in the comments.
